The import of heterocyclic compounds with an unfused imidazole ring to India is projected to see steady growth from 2024 to 2028, with values rising from $153.93 million to $176 million. In 2023, the actual import value stood at $147.32 million, marking a consistent upward trajectory in the subsequent years.
Year-on-year variations indicate gradually increasing import values, reflecting an average annual growth (CAGR) over the five-year forecast period. This consistent increase can be connected to India's growing pharmaceutical and chemical sectors that demand such compounds.
Future trends to watch for include:
- Technological advancements in chemical manufacturing, potentially affecting demand and supply.
- Regulatory changes within the pharmaceutical and chemical industries.
- Global economic conditions influencing trade and import prices.
